Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV), an advanced medical technologies company, today announced it will be presenting SurgiClear™, its new breakthrough surgical...

Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV), an advanced medical technologies company, today announced a multi-year, non-exclusive distribution arrangement with a...

Medical device distributor to market Covalon's antimicrobial coated catheters throughout China and Hong Kong. Ten-year license and distribution agreement includes contractual minimum purchase...

Mr. Brian Pedlar, President and CEO of Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV), an advanced medical technologies company, is pleased to provide the following update. "We...

Will collaborate on development of new biosensors and telehealth technologies with wireless capabilities Mitec invests $2,496,000 for an approximate 9.9% equity interest in Covalon at $0.30 per share